Document Detail

The interrelationship of porcine somatotropin administration and dietary phosphorus on growth performance and bone properties in developing gilts.
MedLine Citation:
PMID:  8226369     Owner:  NLM     Status:  MEDLINE    
Seventy-two gilts (initial weight = 57.9 kg) were used to determine the interrelationship of porcine somatotropin (pST) administration and dietary P on growth performance of finishing gilts (58 to 106 kg) and the effect on bone mechanical properties and mineralization for a 35-d postfinishing phase after withdrawal of pST administration. Gilts were injected daily with placebo (control) or 4 mg of pST and fed .4, .6, or .8% P in the finishing phase. Administration of pST increased ADG and G/F (P < .01) and decreased ADFI (P < .01) during the finishing phase. Increasing dietary P resulted in increased (quadratic, P < .04) ADG from d 0 to 28 of the finishing phase; however, dietary P had no effect (P > .18) on ADG, G/F, or ADFI for the overall finishing phase. When each block weight averaged 106 kg, half the gilts were slaughtered and the first rib, femur, and third and fourth metacarpals were collected. Stress, modulus of elasticity, and ash content of rib, femur, and metacarpals were reduced (P < .06) and femur wall thickness was increased (P < .01) in pST-treated gilts. Increasing dietary P increased (linear, P < .05) bending moment, stress, and ash content for all bones collected, with the exception of metacarpal stress, which was not affected (P > .22). The remaining 36 gilts were individually fed 1.8 kg/d of a common diet to assure a P intake of 22.8 g/d for the 35-d postfinishing phase. Gilts that received higher levels of dietary P during the finishing phase had increased (linear, P < .06) bending moment and ash content for the rib and femur; rib stress, and femur wall thickness were also increased after the postfinishing phase. From d 0 to 28 of the finishing phase, pST-treated gilts required a diet with > .4% P (10.3 g/d P) to maximize growth performance. However, a diet with .4% P (12.44 and 10.66 g/d P, control and pST-treated, respectively) was adequate for growth performance during the overall finishing phase (56 to 106 kg).(ABSTRACT TRUNCATED AT 400 WORDS)
T L Weeden; J L Nelssen; R D Goodband; J A Hansen; K G Friesen; B T Richert
Related Documents :
6375529 - The role of dietary antigen in the aetiology of post weaning diarrhoea.
6517479 - Studies of serum-transferrin and some hematologic parameters in vitamin e and selenium ...
20163469 - Effects of dietary glucose level during late gestation on litter performance and glucos...
22174619 - Rice protein extracted by different methods affects cholesterol metabolism in rats due ...
10434939 - Compensation by pulsatile gnrh infusions for incompetence for oestradiol-induced lh sur...
8129839 - Backfat and carcass composition of piglets fed milk replacers containing vegetable oil ...
25180479 - Effects of an energy-restricted diet rich in plant-derived α-linolenic acid on systemic...
19439329 - Low-carbohydrate diet disrupts the association between insulin resistance and weight gain.
17097809 - Fecal nirs: detection of tick infestations in cattle and horses.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of animal science     Volume:  71     ISSN:  0021-8812     ISO Abbreviation:  J. Anim. Sci.     Publication Date:  1993 Oct 
Date Detail:
Created Date:  1993-12-21     Completed Date:  1993-12-21     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  8003002     Medline TA:  J Anim Sci     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  2683-92     Citation Subset:  IM; S    
Department of Animal Sciences and Industry, Kansas State University, Manhattan 66506-0201.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bone and Bones / drug effects*,  physiology
Calcification, Physiologic / drug effects
Calcium / blood
Eating / drug effects
Elasticity / drug effects
Growth Hormone / pharmacology*
Meat / standards
Parathyroid Hormone / blood
Phosphorus / blood
Phosphorus, Dietary / administration & dosage,  pharmacology*
Random Allocation
Swine / growth & development*,  physiology
Weight Gain / drug effects
Reg. No./Substance:
0/Parathyroid Hormone; 0/Phosphorus, Dietary; 7440-70-2/Calcium; 7723-14-0/Phosphorus; 9002-72-6/Growth Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Effects of porcine somatotropin and dietary phosphorus on growth performance and bone properties of ...
Next Document:  Dietary clofibric acid increases intestinal fatty acid binding protein activity and apparent lipid d...